Stuart Walter Peltz, Chief Executive Officer at PTC THERAPEUTICS, INC. (PTCT), sold 49,365 shares at $60.00 ($3.0M) on 2020-11-04, disclosed to the SEC on 2020-11-06.
Open-market sale of $3.0M PTCT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.00 | 500 | $30K | 1.0% |
| 2 | $60.00 | 1,575 | $95K | 3.2% |
| 3 | $60.00 | 2,362 | $142K | 4.8% |
| 4 | $60.00 | 2,505 | $150K | 5.1% |
| 5 | $60.00 | 3,440 | $206K | 7.0% |
| 6 | $60.00 | 4,900 |
| $294K |
| 9.9% |
| 7 | $60.00 | 7,065 | $424K | 14.3% |
| 8 | $60.00 | 7,560 | $454K | 15.3% |
| 9 | $60.00 | 8,421 | $505K | 17.1% |
| 10 | $60.00 | 11,037 | $662K | 22.4% |
| Total | $60.00 avg | 49,365 | $3.0M | 100% |
| Filing → |
| PTCT | SELL | 2023-01-12 | $257K | — | Filing → |
| PTCT | SELL | 2023-01-11 | $160K | — | Filing → |
| PTCT | SELL | 2022-06-09 | $11K | — | Filing → |